Medical Research Group LLC · Yerevan, Armenia
Rare Disease · Clinical Research
FMF Registry
A1 · Overview

FMF Registry · Overview

The Armenian FMF cohort, presented as a sponsor-grade evidence asset.

Real-world evidence base

For Sponsors

Longitudinal follow-up, attack data, treatment response, and protocol-aligned secondary-use conversations.

Site-anchored cohort

For Sites

The registry is embedded in an established clinical network rather than standing apart from operations.

Aligned oversight

Governance

IRB-aware, sponsor-aligned collaboration model with clear stewardship language.

Multi-protocol utility

Use Cases

Natural history, feasibility, endpoint planning, and post-marketing scenarios.

Page composition

Desktop-first route tuned to the L2 mockup set.

The route uses a dedicated desktop rhythm, with slide-specific heading scale, card density, and supporting route structure aligned to the presentation logic.

Next step

Open the right conversation path.

Use the contact flows for dossier requests, feasibility, registry collaboration, EAEU bridge questions, partner intake, or direct office follow-up.

Go to Contact